Danahy Kevin Patrick's Form 4 filing
Pulse Biosciences, Inc. (PLSE) · filed Feb 23, 2026
- Accession no.
- 0001437749-26-005144
- Filed
- Feb 23, 2026
- Trade date
- Feb 18, 2026
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $118.2K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Danahy Kevin PatrickCIK 0001913245 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Common Stock | MOption exerciseAcquired | +5,000 | $1.53 | +$7,650 | 48,298 | Direct | |
| Feb 18, 2026 | Common Stock | SSaleDisposed | −5,000 | $23.64 | −$118,200 | 43,298 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 300,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.